Our results have also demonstrated that PA-induced NF-κB activation (primary regulator of inflammation in ALI and enhancer of NLRP3 activation) was significantly reduced by pharmacological activation of CB2R. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.